Viral Clearance Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Viral Clearance market was valued at 282 Million US$ in 2018 and is projected to reach 1254 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 20.5% during the forecast period.
This report presents the market size and development trends by detailing the Viral Clearance market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Viral Clearance market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Viral Clearance industry and will help you to build a panoramic view of the industrial development.
Viral Clearance Market, By Type:
Viral Detection Method
Viral Removal Method
Viral Inactivation Method
Viral Clearance Market, By Application:
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics
Some of the leading players are as follows:
Asahi Kasei Bioprocess
MérieuxNutrisciencesItalia
WuXi PharmaTech
Merck KGaA
Eurofins Scientific
Lonza Group
Clean Cells
Creative Biolabs
Charles River Laboratories International
BioScience Laboratories
Vironova Biosafety
BioReliance
Avance Biosciences
BSL BIOSERVICE
BSL-2 Lab
Texcell
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Viral Clearance Market: Technology Type Analysis
-
4.1 Viral Clearance Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Viral Clearance Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Viral Detection Method
4.3.2 Viral Removal Method
4.3.3 Viral Inactivation Method
5 Viral Clearance Market: Product Analysis
-
5.1 Viral Clearance Product Market Share Analysis, 2018 & 2026
-
5.2 Viral Clearance Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Viral Clearance Market: Application Analysis
-
6.1 Viral Clearance Application Market Share Analysis, 2018 & 2026
-
6.2 Viral Clearance Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Blood & Blood Products
6.3.2 Cellular & Gene Therapy Products
6.3.3 Stem Cell Products
6.3.4 Tissue & Tissue Products
6.3.5 Vaccines and Therapeutics
7 Viral Clearance Market: Regional Analysis
-
7.1 Viral Clearance Regional Market Share Analysis, 2018 & 2026
-
7.2 Viral Clearance Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Asahi Kasei Bioprocess
9.1.1 Asahi Kasei Bioprocess Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 MérieuxNutrisciencesItalia
9.2.1 MérieuxNutrisciencesItalia Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 WuXi PharmaTech
9.3.1 WuXi PharmaTech Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Merck KGaA
9.4.1 Merck KGaA Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Eurofins Scientific
9.5.1 Eurofins Scientific Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Lonza Group
9.6.1 Lonza Group Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Clean Cells
9.7.1 Clean Cells Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Creative Biolabs
9.8.1 Creative Biolabs Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Charles River Laboratories International
9.9.1 Charles River Laboratories International Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 BioScience Laboratories
9.10.1 BioScience Laboratories Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Vironova Biosafety
9.11.1 Vironova Biosafety Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 BioReliance
9.12.1 BioReliance Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Avance Biosciences
9.13.1 Avance Biosciences Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 BSL BIOSERVICE
9.14.1 BSL BIOSERVICE Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 BSL-2 Lab
9.15.1 BSL-2 Lab Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Texcell
9.16.1 Texcell Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
The List of Tables and Figures (Totals 102 Figures and 129 Tables)
Figure Viral Detection Method Viral Clearance market, 2015 - 2026 (USD Million)
Figure Viral Removal Method Viral Clearance market, 2015 - 2026 (USD Million)
Figure Viral Inactivation Method Viral Clearance market, 2015 - 2026 (USD Million)
Figure Blood & Blood Products market, 2015 - 2026 (USD Million)
Figure Cellular & Gene Therapy Products market, 2015 - 2026 (USD Million)
Figure Stem Cell Products market, 2015 - 2026 (USD Million)
Figure Tissue & Tissue Products market, 2015 - 2026 (USD Million)
Figure Vaccines and Therapeutics market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Viral Clearance market, by country, 2015 - 2026 (USD Million)
-
Table North America Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table North America Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table North America Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Canada Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Canada Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Europe Viral Clearance market, by country, 2015 - 2026 (USD Million)
-
Table Europe Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Europe Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Europe Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Germany Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Germany Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table France Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table France Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Italy Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Italy Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Spain Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Spain Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Viral Clearance market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table China Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table China Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Japan Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Japan Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table India Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table India Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Viral Clearance market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table MEA Viral Clearance market, by country, 2015 - 2026 (USD Million)
-
Table MEA Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table MEA Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table MEA Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Viral Clearance market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Viral Clearance market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Viral Clearance market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Asahi Kasei Bioprocess Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MérieuxNutrisciencesItalia Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table WuXi PharmaTech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck KGaA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eurofins Scientific Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lonza Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Clean Cells Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Creative Biolabs Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Charles River Laboratories International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BioScience Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Vironova Biosafety Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BioReliance Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Avance Biosciences Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BSL BIOSERVICE Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BSL-2 Lab Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Texcell Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Report Purchase
